ScienceMedia announced today that it has formed a partnership with UL Solutions that offers ComplianceWire®, the industry leading learning management system (LMS) tailored toward compliance and qualification management within life sciences organizations.
People with high blood pressure have a higher risk of cognitive impairment, including dementia, but a new study from researchers at Wake Forest University School of Medicine suggests that engaging in vigorous physical activity more than once a week can lower that risk.
Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heart attack and stroke.
Little is yet known about the health effects of nanoparticles on pregnancy. An interdisciplinary team led by Empa researchers is currently analyzing the risks for babies in the womb. Using a lab model, the researchers were able to determine that certain nanoparticles impair the release of chemical messengers in the placenta and thus the formation of blood vessels. They published their findings in the journal Advanced Science.
Philanthropists Jim and Eleanor Randall and the Randall Family Foundation have given a transformative $100 million gift to the Cedars-Sinai Department of Surgery to propel innovation in surgical care, training and research.
Shlomo Melmed, MB, ChB, executive vice president of Medicine and Health Sciences and dean of the Medical Faculty at Cedars-Sinai, has received the Pituitary Society’s top honor for his four decades of pioneering achievements and leadership in the field of endocrinology.
Tempo Therapeutics, Inc. ("Tempo"), a leading innovator in tissue engineering and regenerative medicine, today announced the addition of Eric I. Richman, MBA to its board of directors.
Nuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and out of the nucleus, regulating many critical cellular functions, such as gene expression, chromatin organization and RNA processes that influence cell survival, proliferation, and differentiation.
Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology.
A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Everybody has them. A Penn State Health expert with nearly 50 years of experience talks about the best way to treat headaches.
Unique program gives dermatology residents a chance to work internationally
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.
Press release announcing Ceevra's certification under EU MDR.
Glaucoma Research Foundation, the nation’s most experienced nonprofit foundation dedicated solely to curing glaucoma and restoring vision through innovative research, recently elected David S. Friedman, MD, PhD, MPH to its Board of Directors.
Mammalian immunity has been shaped from day one by the most successful human pathogens on the planet. Learning how we've evolved together could help scientists understand immune development, treat autoimmune conditions, and make better vaccines.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
